Literature DB >> 24841638

miR-451: potential role as tumor suppressor of human hepatoma cell growth and invasion.

Xuemin Liu1, Xufeng Zhang1, Junxi Xiang1, Yi Lv1, Jianhua Shi1.   

Abstract

Malignant hepatoma is the leading cause of morbidity and mortality in primary liver cancer. MicroRNAs are widely accepted to act as tumor regulators to mediate tumorigenesis. Recently, miRNA-451 (miR-451) has attracted increasing attention due to its critical roles in the development of several types of cancers. Unfortunately, its function and underlying mechanism(s) of action in hepatoma remain unclear. In this study, a significant downregulation of miR-451 was observed in hepatoma cell lines. Its overexpression by administration of miR-451 mimics decreased cell viability and promoted cell apoptosis, indicating a critical role of miR-451 in cell growth. Further mechanistic analysis suggested that miR-451 overexpression accelerated cell death in a caspase-3-dependent manner, as pretreatment with its inhibitor z-VAD-fmk notably attenuated miR-451-induced cell apoptotic rates. Moreover, miR-451 upregulation abrogated cell invasive ability, accompanied with the decrease of matrix metalloproteinase-9 (MMP-9) expression levels, which may contribute to miR-451-triggered cell apoptosis. Taken together, these results reveal a prominent role of miR-451 as a tumor suppressor regulating hepatoma cell growth and invasion in a caspase-3- and MMP-9-dependent manner. Thus, our research supports this promising therapeutic agent against hepatoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24841638     DOI: 10.3892/ijo.2014.2446

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.

Authors:  Amanda Graham; Tommaso Falcone; Warren B Nothnick
Journal:  Hum Reprod       Date:  2015-01-29       Impact factor: 6.918

Review 2.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

3.  miRNA-451 regulates rhesus choroid-retinal endothelial cell function and proteome profile.

Authors:  Hong-Lian Wu; Yan Shao; Zhen-Na Chen; Hui Zhang; Xiao-Min Zhang; Xiao-Rong Li
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

4.  MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.

Authors:  Jia-Yuan Huang; Kai Zhang; Dong-Qin Chen; Jing Chen; Bing Feng; Haizhu Song; Yitian Chen; Ziman Zhu; Lei Lu; Wei De; Rui Wang; Long-Bang Chen
Journal:  Oncotarget       Date:  2015-07-30

Review 5.  Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.

Authors:  Sanjeev K Srivastava; Sumit Arora; Courey Averett; Seema Singh; Ajay P Singh
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

6.  Tumor suppressor activity of miR-451: Identification of CARF as a new target.

Authors:  Ling Li; Ran Gao; Yue Yu; Zeenia Kaul; Jia Wang; Rajkumar S Kalra; Zhenya Zhang; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

7.  The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required.

Authors:  Kai Zhao; Leilei Wang; Tao Li; Meng Zhu; Chen Zhang; Lei Chen; Pengfei Zhao; Hua Zhou; Shengping Yu; Xuejun Yang
Journal:  Int J Oncol       Date:  2017-04-21       Impact factor: 5.650

Review 8.  Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention.

Authors:  Bernhard Biersack
Journal:  Noncoding RNA Res       Date:  2016-07-27

9.  HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9.

Authors:  Dong-Qin Chen; Chen Yu; Xue-Feng Zhang; Zhong-Fang Liu; Rui Wang; Min Jiang; Hao Chen; Feng Yan; Min Tao; Long-Bang Chen; Hong Zhu; Ji-Feng Feng
Journal:  Ther Adv Med Oncol       Date:  2018-07-11       Impact factor: 8.168

10.  Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9.

Authors:  Lichchavi D Rajasinghe; Rohini H Pindiprolu; Smiti Vaid Gupta
Journal:  Onco Targets Ther       Date:  2018-07-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.